Ziopharm Oncology
ZIOP
#8613
Rank
NZ$0.31 B
Marketcap
NZ$1.45
Share price
-0.88%
Change (1 day)
-75.85%
Change (1 year)

Market capitalization of Ziopharm Oncology (ZIOP)

Last known market cap: NZ$0.31 Billion

As of February 2026 Ziopharm Oncology has a market cap of NZ$0.31 Billion. This makes Ziopharm Oncology the world's 8613th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Ziopharm Oncology from 2005 to 2022

End of year Market Cap

Year Marketcap Change
2022NZ$0.29 B-14.56%
2021NZ$0.34 B-53.91%
2020NZ$0.74 B-41.26%
2019NZ$1.27 B183.76%
2018NZ$0.44 B-45.74%
2017NZ$0.82 B-18.66%
2016NZ$1.01 B-36.38%
2015NZ$1.59 B136.62%
2014NZ$0.67 B27.77%
2013NZ$0.52 B25.67%
2012NZ$0.42 B8.82%
2011NZ$0.38 B32.12%
2010NZ$0.29 B72.75%
2009NZ$0.16 B693.3%
2008NZ$21.36 M-78.3%
2007NZ$98.43 M-23.95%
2006NZ$0.12 B275.53%
2005NZ$34.46 M

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Amgen
AMGN
NZ$337.38 B 107,861.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
NZ$18.54 B 5,833.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$206.31 B 65,918.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Cleveland BioLabs
CBLI
NZ$81.94 M-73.78%๐Ÿ‡บ๐Ÿ‡ธ USA